艾滋病毒/艾滋病感染者的生存:来自印度的多中心研究。

IF 0.8 4区 医学 Q4 IMMUNOLOGY
Sanjeev Sinha, Sameer Abdul Samad, Garima Bansal, Saurav Verma, Shashikala Anant Sangle, Subhasish Kamal Guha, Neetu Rajput, Ravindra Mohan Pandey, Sanjay Ranjan, Sonali Salvi, Sanjay Mundhe, Monika More, Dolanchampa Modak, Kalpana Datta, S K Kabra, Rakesh Lodha, Neeraj Nischal, Bimal Kumar Das
{"title":"艾滋病毒/艾滋病感染者的生存:来自印度的多中心研究。","authors":"Sanjeev Sinha,&nbsp;Sameer Abdul Samad,&nbsp;Garima Bansal,&nbsp;Saurav Verma,&nbsp;Shashikala Anant Sangle,&nbsp;Subhasish Kamal Guha,&nbsp;Neetu Rajput,&nbsp;Ravindra Mohan Pandey,&nbsp;Sanjay Ranjan,&nbsp;Sonali Salvi,&nbsp;Sanjay Mundhe,&nbsp;Monika More,&nbsp;Dolanchampa Modak,&nbsp;Kalpana Datta,&nbsp;S K Kabra,&nbsp;Rakesh Lodha,&nbsp;Neeraj Nischal,&nbsp;Bimal Kumar Das","doi":"10.2174/1570162X21666230123151639","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It has been more than 17 years since the introduction of free ART in India. At this point, it would be prudent to look at the factors associated with the survival of persons living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) (PLHA) who are already enrolled in the ART program.</p><p><strong>Methods: </strong>PLHAs enrolled from antiretroviral therapy (ART) centers located in three different cities in India - Delhi, Pune and Kolkata, and were followed up at six monthly intervals monitoring the WHO stage, CD4 counts, complete blood counts, and liver and kidney function tests, for a duration of three years.</p><p><strong>Results and discussion: </strong>The incidence of mortality among HIV/AIDS patients on ART was 5.0 per 1000 patient-years (21/1410, 1.4%). Age at initiation of ART, being above 35 years, was the only significant predictor of mortality (log-rank p = 0.018). Multivariable analysis showed a significant association of an unfavourable outcome (defined as mortality or development of opportunistic infection during follow-up) with male gender (adjusted odds ratio (AOR) = 5.26, p = <0.01) and being unmarried at ART initiation (AOR = 1.39, p = 0.005).</p><p><strong>Conclusion: </strong>The survival of PLHA with good adherence to ART is independent of the WHO stage or CD4 counts at the initiation of ART. Initiation of ART after 35 years of age was a significant predictor of mortality.</p>","PeriodicalId":10911,"journal":{"name":"Current HIV Research","volume":"21 1","pages":"81-87"},"PeriodicalIF":0.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Survival of Persons Living With HIV/AIDS: A Multicentric Study From India.\",\"authors\":\"Sanjeev Sinha,&nbsp;Sameer Abdul Samad,&nbsp;Garima Bansal,&nbsp;Saurav Verma,&nbsp;Shashikala Anant Sangle,&nbsp;Subhasish Kamal Guha,&nbsp;Neetu Rajput,&nbsp;Ravindra Mohan Pandey,&nbsp;Sanjay Ranjan,&nbsp;Sonali Salvi,&nbsp;Sanjay Mundhe,&nbsp;Monika More,&nbsp;Dolanchampa Modak,&nbsp;Kalpana Datta,&nbsp;S K Kabra,&nbsp;Rakesh Lodha,&nbsp;Neeraj Nischal,&nbsp;Bimal Kumar Das\",\"doi\":\"10.2174/1570162X21666230123151639\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>It has been more than 17 years since the introduction of free ART in India. At this point, it would be prudent to look at the factors associated with the survival of persons living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) (PLHA) who are already enrolled in the ART program.</p><p><strong>Methods: </strong>PLHAs enrolled from antiretroviral therapy (ART) centers located in three different cities in India - Delhi, Pune and Kolkata, and were followed up at six monthly intervals monitoring the WHO stage, CD4 counts, complete blood counts, and liver and kidney function tests, for a duration of three years.</p><p><strong>Results and discussion: </strong>The incidence of mortality among HIV/AIDS patients on ART was 5.0 per 1000 patient-years (21/1410, 1.4%). Age at initiation of ART, being above 35 years, was the only significant predictor of mortality (log-rank p = 0.018). Multivariable analysis showed a significant association of an unfavourable outcome (defined as mortality or development of opportunistic infection during follow-up) with male gender (adjusted odds ratio (AOR) = 5.26, p = <0.01) and being unmarried at ART initiation (AOR = 1.39, p = 0.005).</p><p><strong>Conclusion: </strong>The survival of PLHA with good adherence to ART is independent of the WHO stage or CD4 counts at the initiation of ART. Initiation of ART after 35 years of age was a significant predictor of mortality.</p>\",\"PeriodicalId\":10911,\"journal\":{\"name\":\"Current HIV Research\",\"volume\":\"21 1\",\"pages\":\"81-87\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current HIV Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/1570162X21666230123151639\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current HIV Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1570162X21666230123151639","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:印度引入免费ART已有17年多了。在这一点上,谨慎的做法是考虑与已经参加抗逆转录病毒治疗计划的人类免疫缺陷病毒(HIV)/获得性免疫缺陷综合症(AIDS)感染者的生存相关的因素。方法:从位于印度德里、浦那和加尔各答三个不同城市的抗逆转录病毒治疗(ART)中心招募的艾滋病患者,每隔6个月进行随访,监测WHO分期、CD4计数、全血细胞计数以及肝肾功能检测,持续3年。结果与讨论:接受抗逆转录病毒治疗的HIV/AIDS患者死亡率为5.0 / 1000患者-年(21/1410,1.4%)。35岁以上开始ART治疗的年龄是死亡率的唯一显著预测因子(log-rank p = 0.018)。多变量分析显示,不利结果(定义为随访期间死亡率或机会性感染的发生)与男性性别显著相关(调整优势比(AOR) = 5.26, p =)。结论:坚持抗逆转录病毒治疗的PLHA患者的生存率与抗逆转录病毒治疗开始时的WHO分期或CD4计数无关。35岁以后开始抗逆转录病毒治疗是死亡率的重要预测指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Survival of Persons Living With HIV/AIDS: A Multicentric Study From India.

Background: It has been more than 17 years since the introduction of free ART in India. At this point, it would be prudent to look at the factors associated with the survival of persons living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) (PLHA) who are already enrolled in the ART program.

Methods: PLHAs enrolled from antiretroviral therapy (ART) centers located in three different cities in India - Delhi, Pune and Kolkata, and were followed up at six monthly intervals monitoring the WHO stage, CD4 counts, complete blood counts, and liver and kidney function tests, for a duration of three years.

Results and discussion: The incidence of mortality among HIV/AIDS patients on ART was 5.0 per 1000 patient-years (21/1410, 1.4%). Age at initiation of ART, being above 35 years, was the only significant predictor of mortality (log-rank p = 0.018). Multivariable analysis showed a significant association of an unfavourable outcome (defined as mortality or development of opportunistic infection during follow-up) with male gender (adjusted odds ratio (AOR) = 5.26, p = <0.01) and being unmarried at ART initiation (AOR = 1.39, p = 0.005).

Conclusion: The survival of PLHA with good adherence to ART is independent of the WHO stage or CD4 counts at the initiation of ART. Initiation of ART after 35 years of age was a significant predictor of mortality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current HIV Research
Current HIV Research 医学-病毒学
CiteScore
1.90
自引率
10.00%
发文量
81
审稿时长
6-12 weeks
期刊介绍: Current HIV Research covers all the latest and outstanding developments of HIV research by publishing original research, review articles and guest edited thematic issues. The novel pioneering work in the basic and clinical fields on all areas of HIV research covers: virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Periodically, the journal invites guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信